Medicine News and Research

RSS

Advanced BioHealing to present industry experience at 2010 World Stem Cell Summit

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Senior Vice President, Dean Tozer and Vice President of Government Affairs and Health Economics, Therésa Dixon will speak on behalf of the Company at the 2010 World Stem Cell Summit, sharing their more than 30 years of combined industry experience with attendees.

4 Oct 2010

NIH to award $64M under Transformative Research Projects program

The National Institutes of Health will award up to $64 million over five years to encourage exploration of exceptionally innovative and original research ideas that have the potential for extraordinary impact.

4 Oct 2010

Californian Hispanics at lower risk of developing melanoma, but develop the disease at younger age

Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.

4 Oct 2010

Study demonstrates potential of nontoxic envelope proteins as an alternative to pseudotype lentiviral vectors

Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.

4 Oct 2010

$3.4M grant for study to distinguish bacterial infections from viral infections in infants with fevers

Octavio Ramilo, MD, chief of Infectious Diseases at Nationwide Children's Hospital, is one of three principal investigators who will share in a five-year, $3.4 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Ramilo and a team of more than 50 physicians across the United States are investigating the use of novel technologies for distinguishing between bacterial and viral infections in infants with fevers within emergency departments.

4 Oct 2010

Cancer patients likely to experience memory impairment: Study

People with a history of cancer have a 40 percent greater likelihood of experiencing memory problems that interfere with daily functioning, compared with those who have not had cancer, according to results of a new, large study.

4 Oct 2010

New quantitative methods to detect small signs of tremor

Sensitive new quantitive methods could be used to detect small signs of increased tremor and impaired motor skills caused by exposure to certain metals, and to follow up the treatment of neurological disorders, reveals a thesis from the University of Gothenburg, Sweden.

4 Oct 2010

Maven Semantic updates Urinary Incontinence research database

Maven Semantic announces updates to their Urinary Incontinence research database.

4 Oct 2010

UCI awarded $10M grant to explore ways of preventing staph infections in people harboring MRSA bacteria

A UC Irvine infectious disease specialist has received a three-year, $10 million grant to explore the effectiveness of new methods to prevent staph infections in people who harbor MRSA bacteria when they're discharged from the hospital.

4 Oct 2010

NIH announces T-R01 project award to examine human microbiome

The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.

4 Oct 2010

Researchers identify ways to predict embryonic developmental success

Two-thirds of all human embryos fail to develop successfully. Now, in a new study, researchers at the Stanford University School of Medicine have shown that they can predict with 93 percent certainty which fertilized eggs will make it to a critical developmental milestone and which will stall and die. The findings are important to the understanding of the fundamentals of human development at the earliest stages, which have largely remained a mystery despite the attention given to human embryonic stem cell research.

4 Oct 2010

Researchers create new cell lines from mesenchymal stem cells

Biomedical researchers at the University at Buffalo have engineered adult stem cells that scientists can grow continuously in culture, a discovery that could speed development of cost-effective treatments for diseases including heart disease, diabetes, immune disorders and neurodegenerative diseases.

4 Oct 2010

Advances in treatment and management of neurological disorders

The latest advances in treating neurologic disorders such as stroke, headache, Parkinson's disease, epilepsy and sleep disorders are detailed in a special issue of the journal Neurologic Clinics.

4 Oct 2010

New edition of Sturge-Weber Syndrome textbook published

Eleven years after the first edition, a new edition of the Sturge-Weber Syndrome textbook has been published by the Sturge-Weber Foundation in New Jersey. Co-author E. Steve Roach, MD, is chief of Neurology and vice-chair of Pediatrics at Nationwide Children's Hospital.

4 Oct 2010

AVEO Pharmaceuticals to present tivozanib Phase 2 study results at IKCS Symposium

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.

4 Oct 2010

BCBC awards grant for cell therapy research in type 1 diabetes

Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.

4 Oct 2010

Chronic infection with S. maltophilia bacterium may impact cystic fibrosis progression: Study

Exacerbations in cystic fibrosis (CF) may be linked to chronic infection with a bacterium called Stenotrophomonas maltophilia, which was previously thought to simply colonize the CF lung. The finding that chronic infection with S. maltophilia is independently linked with an increased risk of exacerbations gives clinicians and researchers a new potential measure of the health status of CF patients, as well as a new potential target in fighting their disease.

4 Oct 2010

PET imaging technique helps early treatment response assessment for cisplatin-resistant ovarian cancer

Research reported in the October issue of The Journal of Nuclear Medicine (JNM) shows that a molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer.

4 Oct 2010

Look AHEAD intervention program improves risk factors in obese, type 2 diabetic patients

An intensive lifestyle intervention program designed to achieve and maintain weight loss improves diabetes control and cardiovascular disease risk factors in overweight and obese individuals with type 2 diabetes, according to four-year results of the Look AHEAD study, funded by the National Institutes of Health and the Centers for Disease Control and Prevention. The results are published in the Sept. 27, 2010, issue of the Archives of Internal Medicine.

4 Oct 2010

NIH announces it will share IP rights to some AIDS drugs in UNITAID Patent Pool

The NIH announced Thursday it will share intellectual property rights on some AIDS drugs in a patent pool designed to make treatments more widely available to the poor, Reuters reports.

4 Oct 2010

Medicine News and Research

Advanced BioHealing to present industry experience at 2010 World Stem Cell Summit

NIH to award $64M under Transformative Research Projects program

Californian Hispanics at lower risk of developing melanoma, but develop the disease at younger age

Study demonstrates potential of nontoxic envelope proteins as an alternative to pseudotype lentiviral vectors

$3.4M grant for study to distinguish bacterial infections from viral infections in infants with fevers

Cancer patients likely to experience memory impairment: Study

New quantitative methods to detect small signs of tremor

Maven Semantic updates Urinary Incontinence research database

UCI awarded $10M grant to explore ways of preventing staph infections in people harboring MRSA bacteria

NIH announces T-R01 project award to examine human microbiome

Researchers identify ways to predict embryonic developmental success

Researchers create new cell lines from mesenchymal stem cells

Advances in treatment and management of neurological disorders

New edition of Sturge-Weber Syndrome textbook published

AVEO Pharmaceuticals to present tivozanib Phase 2 study results at IKCS Symposium

BCBC awards grant for cell therapy research in type 1 diabetes

Chronic infection with S. maltophilia bacterium may impact cystic fibrosis progression: Study

PET imaging technique helps early treatment response assessment for cisplatin-resistant ovarian cancer

Look AHEAD intervention program improves risk factors in obese, type 2 diabetic patients

NIH announces it will share IP rights to some AIDS drugs in UNITAID Patent Pool

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News